logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Toru Mukohara

national cancer center - japan
H指数:32
被引数:5,855

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Potential of β-catenin inhibitors as a novel therapeutic strategy for PIK3CA/CTNNB1 double-mutant endometrial cancer

β-连环蛋白抑制剂作为PIK3CA/CTNNB1双突变子宫内膜癌的新型治疗策略的潜力

Cell Death Discovery
IF7
2026-09-260
OA
Takehiro Nakao; Ryo Kamata; Hitoshi Saito; Gaku Yamamoto; Tomoko Y. Morita; Kumi Kinoshita; Yui Takahashi; Chiaki Mashima; Toyohiro Yamauchi; Yuta Sakae; Misato Kamii; Kazuki Nakai; Yumi Hakozaki; Hiromichi Nakajima; Kenichi Harano; Yoichi Naito; Toru Mukohara; Akihiro Ohashi
Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort

基于基因组分析的第二阶段临床试验：BELIEVE试验（NCCH1901）亚组研究

Cancer Science
IF4.3
2026-08-180
OAAI
Masashi Kanai; Kuniko Sunami; Tatsunori Shimoi; Satoshi Nishiwaki; Ichiro Kinoshita; Tetsuhiro Yoshinami; Chigusa Morizane; Yusuke Sato; Toshio Kubo; Mamoru Ito; Hiroshi Nishihara; Toru Mukohara; Hidekazu Shirota; Ryo Ko; Taro Shibata; Manabu Muto; Noboru Yamamoto
Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLE

曲妥珠单抗德鲁替康再次治疗在HER2阳性转移性乳腺癌中的应用：EN-SEMBLE

Breast
IF7.9
2026-08-010
PRE
Nozawa, Kazuki; Iwata, Hiroji; Mukohara, Toru; Taira, Tetsuhiko; Yoshimura, Akiyo; Nagai, Shigenori E.; Hashimoto, Jun; Matsuura, Kazuo; Mizuno, Toshiro; Shinden, Yoshiaki; Yamamoto, Mitsugu; Takano, Toshimi; Wakahara, Makoto; Terakawa, Hirofumi; Yamanaka, Takashi; Kojima, Yasuyuki; Nakayama, Takahiro; Hirakawa, Yuji; Shiosakai, Kazuhito; Tsurutani, Junji
Efficacy of perioperative pembrolizumab for triple-negative breast cancer with apocrine feature or metaplastic carcinoma

三阴性乳腺癌伴顶泌特征或化生性癌的围手术期帕博利珠单抗疗效

The Oncologist
IF0
2026-04-250
OA
Nobuyuki Takahashi; Chikako Funasaka; Mai Shimura; Akira Hirota; Mao Uematsu; Misao Fukuda; Kaede Baba; Kanako Mamishin; Hiromichi Nakajima; Chihiro Kondoh; Kenichi Harano; Nobuaki Matsubara; Ako Hosono; Toshikatsu Kawasaki; Tatsuya Onishi; Yoichi Naito; Toru Mukohara
Impact of platinum-free interval and bevacizumab on second-line chemotherapy following progression on first-line PARP inhibitor maintenance in advanced ovarian cancer: A retrospective cohort study

铂类停药间隔期及贝伐珠单抗对进展后序贯二线化疗的影响：一项回顾性队列研究（基于晚期卵巢癌一线PARP抑制剂维持治疗后进展）

Gynecologic Oncology
IF3.7
2025-11-220
OAAI
Miki Hayakawa; Hiromichi Nakajima; Kenichi Harano; Shogo Watanabe; Saki Tsuchimochi; Mao Uematsu; Misao Fukuda; Chikako Funasaka; Chihiro Kondoh; Nobuaki Matsubara; Yoichi Naito; Ako Hosono; Masashi Wakabayashi; Kazuaki Takahashi; Hiroshi Tanabe; Toru Mukohara
Exploring Health Care Needs and HR-QOL Among Women With Cancer: A Principal Component Analysis Before and 6 Months After Treatment Initiation

探索癌症女性患者的医疗需求与健康相关生活质量：治疗开始前及治疗开始后6个月的主成分分析

Journal of Clinical Nursing
IF3.5
2025-10-290
PRE
Michiyo Mizuno; Ikuko Chiba; Natsumi Oda; Miki Kondo; Toru Mukohara; Tatsuya Onishi; Choei Tai; Yui Nakagawa; Ako Hosono; Susumu Okano; Hiroshi Tanabe; Saori Mishima; Masami Yuda; Tetsuo Akimoto
Effectiveness of post-trastuzumab deruxtecan treatments and incidence of interstitial lung disease in HER2-positive metastatic breast cancer: a real-world, observational cohort study☆

曲妥珠单抗德鲁克替康治疗后疗效及间质性肺病发生率：一项真实世界、观察性队列研究

ESMO Open
IF8.3
2025-07-250
OAAI
K. Nozawa; H. Iwata; T. Mukohara; T. Taira; A. Yoshimura; S.E. Nagai; J. Hashimoto; K. Matsuura; T. Mizuno; Y. Shinden; M. Yamamoto; T. Takano; M. Wakahara; H. Terakawa; T. Yamanaka; Y. Kojima; T. Nakayama; Y. Hirakawa; K. Kuge; A. Tanabe; J. Tsurutani
Overall efficacy and safety of olanzapine 5 mg added to triplet antiemetics for an anthracycline-containing regimen in patients with breast cancer: a phase 3, double-blind, randomised, placebo-controlled trial

奥氮平5 mg联合三联止吐药方案用于含蒽环类药物方案乳腺癌患者的总体有效性与安全性：一项III期、双盲、随机、安慰剂对照试验

lancet oncology
IF0
2025-06-180
PRE
Mitsue Saito; Hirotoshi Iihara; Mototsugu Shimokawa; Ryoko Udagawa; Michiko Tsuneizumi; Manabu Futamura; Yuko Ishikawa; Hideaki Ogata; Hiroko Bando; Hiroaki Shima; Keiko Hosoya; Toru Mukohara; Kenichiro Tanaka; Tomoki Ikuta; Takahiko Kawate; Kazushige Ishida; Katsuya Nakai; Toshitaka Uomori; Goro Kutomi; Rie Ozeki; Naotake Yanagisawa
Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial (jun, 10.1038/s41591-024-03060-0, 2024)
NATURE MEDICINE
IF50
2024-06-240
OAAI
Mukohara, Toru; Park, Yeon Hee; Sommerhalder, David; Yonemori, Kan; Hamilton, Erika; Kim, Sung-Bae; Kim, Jee Hyun; Iwata, Hiroji; Yamashita, Toshinari; Layman, Rachel M.; Mita, Monica; Clay, Timothy; Chae, Yee Soo; Oakman, Catherine; Yan, Fengting; Kim, Gun Min; Im, Seock-Ah; Lindeman, Geoffrey J.; Rugo, Hope S.; Liyanage, Marlon; Saul, Michelle; Le Corre, Christophe; Skoura, Athanasia; Liu, Li; Li, Meng; LoRusso, Patricia M.
Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial
NATURE MEDICINE
IF50
2024-06-012
OAAI
Mukohara, Toru; Park, Yeon Hee; Sommerhalder, David; Yonemori, Kan; Hamilton, Erika; Kim, Sung-Bae; Kim, Jee Hyun; Iwata, Hiroji; Yamashita, Toshinari; Layman, Rachel M.; Mita, Monica; Clay, Timothy; Chae, Yee Soo; Oakman, Catherine; Yan, Fengting; Kim, Gun Min; Im, Seock-Ah; Lindeman, Geoffrey J.; Rugo, Hope S.; Liyanage, Marlon; Saul, Michelle; Le Corre, Christophe; Skoura, Athanasia; Liu, Li; Li, Meng; LoRusso, Patricia M.

研究方向

暂未获取到该数据
H
Hironobu Minami
H 指数:55论文数:699被引数:1.5万
Y
Yoichi Naito
H 指数:35论文数:354被引数:4,988
N
Naomi Kiyota
H 指数:44论文数:349被引数:1.4万
T
Takahiro Kogawa
H 指数:23论文数:243被引数:2,137
K
Kenichi Harano
H 指数:21论文数:184被引数:1,367
A
Ako Hosono
H 指数:20论文数:116被引数:1,473
T
Toshimi Takano
H 指数:36论文数:394被引数:8,064
N
Nobuaki Matsubara
H 指数:39论文数:463被引数:1.2万
Y
Yohei Funakoshi
H 指数:18论文数:109被引数:1,873
H
Hiroji Iwata
H 指数:89论文数:844被引数:5.7万